4.shock & monitoring

Upload: drgbhanu-prakash

Post on 29-May-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/9/2019 4.Shock & Monitoring

    1/21

    Shock

    Differential Diagnosis and HemodynamicMonitoring

    www.gims-org.com

  • 8/9/2019 4.Shock & Monitoring

    2/21

  • 8/9/2019 4.Shock & Monitoring

    3/21

    Classification of Shock

    Hypovolemic

    Septic/Inflammatory

    Cardiogenic (Intrinsic, compressive &Obstructive)

    NeurogenicAnaphylactic

  • 8/9/2019 4.Shock & Monitoring

    4/21

    Clinical Markers of Shock

    K

    lkj

    Brachial systolic blood pressure: 90 beats/min

    Respiratory rate: 29 breaths/min

    Urine Output:

  • 8/9/2019 4.Shock & Monitoring

    5/21

    Etiology & Hemodynamic Changes

    in Shock

    Etiology ofshock

    example CVP CO SVR VO2 sat

    preload hypovolemic low low high low

    contractility cardiogenic high low high low

    afterload distributive

  • 8/9/2019 4.Shock & Monitoring

    6/21

    Etiology & Hemodynamic Changes

    in Shock (Afterload)

    ETIOLOGYOF SHOCK

    EXAMPLE CVP CO SVR VO2 SAT

    AFTERLOAD DISTRIBUTIVE

    Hyperdynamic Septic Low/High High Low High

    HypodynamicSeptic

    Low/High Low High Low/High

    Neurogenic Low Low Low Low

    Anaphylactic Low Low Low Low

  • 8/9/2019 4.Shock & Monitoring

    7/21

    Hypovolemic Shock

    Decreased preload->small ventricular end-diastolicvolumes -> inadequate cardiac generation of pressureand flow

    Causes:

    -- bleeding: trauma, GI bleeding, ruptured aneurysms,hemorrhagic pancreatitis

    -- protracted vomiting or diarrhea

    -- adrenal insufficiency; diabetes insipidus

    -- dehydration

    -- third spacing: intestinal obstruction, pancreatitis,

    cirrhosis

  • 8/9/2019 4.Shock & Monitoring

    8/21

    Hypovolemic Shock

    Signs & Symptoms: Hypotension, Tachycardia,MS change, Oliguria, Deminished Pulses.

    Markers: monitor UOP,CVP, BP, HR, Hct, MS,

    CO, lactic acid and PCWP

    Treatment: ABCs, IVF (crystalloid), Trasfusion

    Stem ongoing Blood Loss

    Patients on -blockers, w/ spinal shock &athletes may not be tachycardic

  • 8/9/2019 4.Shock & Monitoring

    9/21

    Septic/Inflammatory Shock

    Mechanism: release of inflammatory mediators leading to

    1. Disruption of the microvascular endothelium

    2. Cutaneous arteriolar dilation and sequestration of blood in

    cutaneous venules and small veins

    Causes:

    1. Anaphylaxis, drug, toxin reactions

    2. Trauma: crush injuries, major fractures, major burns.

    3. infection/sepsis: G(-/+ ) speticemia, pneumonia,peritonitis, meningitis, cholangitis, pyelonephritis,

    necrotic tissue, pancreatitis, wet gangrene, toxic shocksyndrome, etc.

  • 8/9/2019 4.Shock & Monitoring

    10/21

    Septic/Inflammatory ShockSigns: Early warm w/ vasodilation, often adequate urine

    output, febrile, tachypneic.Late-- vasoconstriction, hypotension, oliguria,altered mental status.

    Monitor/findings: Earlyhyperglycemia, respiratory

    alkylosis, hemoconcentration,WBC typically normal or low.

    Late Leukocytosis, lactic acidosisVery Late Disseminated Intravascular

    Coagulation & Multi-OrganSystem Failure.

    Tx : ABCs, IVF, Blood cx, ABX, Drainage (ie abscess)pressors.

  • 8/9/2019 4.Shock & Monitoring

    11/21

    Cardiogenic ShockMechanism: Intrinsic abnormality of heart -> inability to

    deliver blood into the vasculature with adequate power

    Causes:

    1. Cardiomyopathies: myocardial ischemia, myocardial infarction,

    cardiomyopathy, myocardiditis, myocardial contusion2. Mechanical: cardiac valvular insufficiency, papillary muscle

    rupture, septal defects, aortic stenosis

    3. Arrythmias: bradyarrythmias (heart block), tachyarrythmias

    (atrial fibrillation, atrial flutter, ventricular fibrillation)

    4. Obstructive disorders: PE, tension peneumothorax, pericardialtamponade, constrictive pericaditis, severe pulmonaryhypertension

  • 8/9/2019 4.Shock & Monitoring

    12/21

    Cardiogenic Shock

    Characterized by high preload (CVP) with low CO

    Signs/SXS: Dyspnea, rales, loud P2 gallop, low BP,oliguria

    Monitor/findings: CXR pulm venous congestion, elevated

    CVP, Low CO. Tx: CHF diuretics & vasodilators +/- pressors.

    LV failure pressors, decrease afterload,

    intraaortic ballon pump &

    ventricular assist device.

  • 8/9/2019 4.Shock & Monitoring

    13/21

    Neurogenic Shock

    Causes:

    1. Spinal cord injury

    2. Regional anesthesia

    3. Drugs

    4. Neurological disorders

    Mechanism: Loss of autonomic innervation of thecardiovascular system (arterioles, venules, smallveins, including the heart)

  • 8/9/2019 4.Shock & Monitoring

    14/21

    Neurogenic Shock

    Characterized by loss of vascular tone & reflexes.

    Signs: Hypotension, Bradycardia, Accompanying

    Neurological deficits.

    Monitor/findings: hemodynamic instability, test bulbo-carvernous reflex

    Tx: IVF, vasoactive medications if refractory

  • 8/9/2019 4.Shock & Monitoring

    15/21

    Monitoring Adjuncts in Shock

    Sphyngomanometry

    Pulse Oximeter

    Arterial Line

    Central Venous Line (Cordice, Triple Lumen,Pulmonary Artery Catheter)

  • 8/9/2019 4.Shock & Monitoring

    16/21

    Pulmonary Artery

    Catheterization

    K

    lkj

    Allows for accurate and continuous hemodynamic monitoringin shock patients

    1. Evaluate Fluid Resuscitation

    2. Titration of Vasoactive Medications

    3. Allows for Assessment of Cardiovascular

    Performance.

    4. Monitor the Effects of Changes in Mechanical

    Ventilation.

  • 8/9/2019 4.Shock & Monitoring

    17/21

    Pulmonary Artery

    Catheterization

    K

    lkj

  • 8/9/2019 4.Shock & Monitoring

    18/21

    Pulmonary ArteryCatheterization: cardiovascular

    performance

    K

    lkj

    Central Venous Pressure (CVP):

    CVP = right atrial pressure (RAP) = right-ventricularend-diastolic pressure (RVEDP) (Right VentricularPreload)

    Pulmonary Capillary Wedge Pressure (PCWP)

    PCWP = left atrial pressure (LAP) = left-ventricularend-diastolic pressure (LVEDP) (Left VentricularPreload)

  • 8/9/2019 4.Shock & Monitoring

    19/21

    Cardiovascular Performance

    K

    lkj

    Cardiac Output (CO) = HR x SV (L/min)

    Normal CO = 4 to 8 L/min

    Cardiac Index (CI) = CO/BSA (L/min/m2)

    Normal CI = 2.5-4.2 L/min/m2

    Stroke Volume Index (SVI): CI/HR (ml/beat/m2)

    Normal SVI = 40-85 ml/beat/m2

    Systemic Vascular Resistance = MAP CVP / CO x 80

    Normal SVR = 900-1600 dynes/sec/cm-5

    Systemic Vascular Resistance Index = MAP CVP / CI x 80

    Normal SVRI = 1970-2390 dynes/sec/cm-5

  • 8/9/2019 4.Shock & Monitoring

    20/21

    Pulmonary ArteryCatheterization: systemic oxygen

    transport

    K

    lkj

    Oxygen Delivery (DO2) [520-570 mL/min x m2]: rate

    of oxygen transport in arterial blood

    DO2= CI x 13.4 x Hb x SaO2

    Oxygen Uptake (VO2) [110-160 ml/min x m2]: rate of

    oxygen taken up from the systemic microcirculation

    VO2 = CI x 13.4 x Hb x (SaO2 SvO2)

  • 8/9/2019 4.Shock & Monitoring

    21/21

    Hemodynamic Profiles

    Klkj

    PCWP CVP CO/CI SVR/IHypovolemic Low Low Low High

    Cardiogenic High High Low High

    Inflammatory Low / N Low/N High Low

    Neurogenic Low Low Low Low

    Shock